Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LBL-015 by Leads Biolabs for Lymphoma: Likelihood of Approval
LBL-015 is under clinical development by Leads Biolabs and currently in Phase II for Lymphoma. According to GlobalData, Phase II...